Hematologist
CION Cancer Clinics
AML in patients over 70: intensive or not | CION Cancer Clinics
Age alone does not decide AML treatment. Most people over 70 are offered lower-intensity treatment, because intensive chemotherapy carries a high risk of serious harm. A few fit older adults with favourable leukaemia types may still be offered it. The choice rests on fitness, the genetic tests and what your parent wants. This page explains the three paths and how the decision is made. At CION Cancer Clinics, every leukaemia, MDS and MPN case is reviewed by our haematologist and discussed at a tumour board before a plan is agreed.
BP
Medically reviewed by Dr. Basudev PokhrelConsultant Haematologist · last reviewed September 2026, next review due September 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Should a parent over 70 with AML have intensive chemotherapy?
- What are the treatment paths for older adults?
- How will the team reach a decision with you?
- What do the words doctors use mean?
- What do families often believe that is not quite right?
- What can this page not tell you?
- Common questions about AML treatment in older adults
The short answer
Should a parent over 70 with AML have intensive chemotherapy?
Age alone does not decide it. Most people over 70 with AML are offered lower-intensity treatment, because intensive chemotherapy carries a high risk of serious harm at this age. A few fit older adults with favourable leukaemia types may still be offered intensive treatment.
What the team actually weighs
The haematologist looks at how active and independent your parent is, how well the heart, lungs, kidneys and liver work, and whether there is diabetes or other long-standing illness. The genetic tests on the leukaemia matter just as much. Some types respond well to intensive treatment. Others respond poorly to it even in younger people.
What your parent wants matters too
Some older people want every possible treatment. Others care most about staying at home, avoiding long admissions and being with family. Neither choice is wrong. Tell the team what your parent values, in their own words, before a plan is fixed.
Why intensive treatment is harder at this age
Older marrow recovers more slowly after chemotherapy, so the weeks of very low counts last longer. Infections are more likely and harder to shake off. AML in older adults also more often carries genetic changes that respond poorly to intensive chemotherapy. Put together, the harm can outweigh the gain for many people, even when they seem strong.
AML often moves fast. Genetic results can take some days, and the team may need to start supportive treatment while waiting.The options
What are the treatment paths for older adults?
Broadly three. The team may also move from one to another as things change.
Intensive chemotherapy
Several weeks in hospital with very low counts, aiming for deep remission and sometimes a transplant later.
May suit
- Fit, independent older adults
- Favourable genetic types
Does not suit
- Frail people or those with serious heart or lung disease
Lower-intensity treatment
Combinations such as venetoclax with azacitidine, or other gentler drugs, given in cycles with much of the care as day care. It still lowers counts and needs close watching.
This is active treatment aimed at controlling the leukaemia, not only comfort care.Supportive care
Transfusions, infection treatment and symptom control, without treatment aimed at the leukaemia itself. Sometimes a mild tablet is used to keep very high white counts down. It can be the right choice for people who are very unwell or who do not want further treatment.
Focuses on
- Comfort and time at home
- Fewer hospital visits
Not sure whether this applies to you?
Ask an oncologistHow the choice is made
How will the team reach a decision with you?
A fitness assessment
The team asks what your parent manages day to day: walking, bathing, climbing stairs, going out. Heart, kidney and lung tests are done. This gives a far better picture than age. Memory, mood and nutrition may be checked too.
The leukaemia tests
Marrow and genetic tests show the AML type and mutations. Some results point towards particular drugs or away from intensive treatment.
The family conversation
The haematologist explains the likely benefits and harms of each path for your parent. Bring the family members who will share decisions, and let your parent speak first. Ask anything that is unclear, more than once if needed.
Start and review
Treatment begins and is reviewed after the first cycle or two. If it is too hard or not working, the plan can be changed. Tell the team honestly how your parent is coping at home, because clinic visits show only part of the picture.
In the consultation
What do the words doctors use mean?
- Fit or unfit
- Whether intensive treatment is judged safe enough, based on overall health rather than age alone.
- Performance status
- A score describing how active and independent a person is. Lower scores mean more active.
- Comorbidities
- Other long-term illnesses, such as diabetes, heart disease or kidney disease.
- Frailty
- Reduced strength and reserve, which makes recovery from illness harder.
- Supportive care
- Comfort-focused care, including transfusions and infection treatment, without treatment aimed at the leukaemia itself.
- Reduced-intensity
- A gentler version of a treatment, such as a transplant with milder preparation, used for people who could not cope with the full version.
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Commonly believed
What do families often believe that is not quite right?
"At his age, nothing can be done."
That is rarely true today. Lower-intensity treatments have given many older adults with AML more good time, often mostly at home. Ask what is possible before deciding.
"Stronger treatment always means longer life."
For many older adults, intensive chemotherapy brings serious infections and long admissions without extra benefit. The strongest option is not always the one that helps most.
"We should not tell Amma it is leukaemia."
Treatment decisions at this age depend heavily on what the person wants. Most older people cope better with gentle honesty, with family present, than with being kept out of the discussion.
"Choosing supportive care means abandoning him."
Supportive care is active care. Transfusions, infection treatment and symptom control continue, and the team stays involved.
Being straight with you
What can this page not tell you?
It cannot tell you which path is right for your parent. That depends on the fitness assessment, the genetic results and your parent's wishes, and only the treating team has all three. It also cannot give you a number for how long treatment will help. Outlook in older adults varies widely with the leukaemia type and general health.
Caring for an older parent through treatment
Even lower-intensity treatment means frequent hospital visits, blood tests and transfusions, especially early on. Someone needs to be available to bring your parent in, watch for fever and call the team. If family members live far away or work long hours, plan this before treatment starts, and tell the team if it is not possible.
Questions worth asking
How fit is my parent for each option? What did the genetic tests show? What would a typical week look like? What happens if treatment is too hard? Whom do we call at night? Writing these down before the appointment helps.
Did you know
At CION, the haematology team takes complex AML decisions to a tumour board, so the recommendation for an older patient is not one doctor's view. Where specialist tests or transplant assessment are needed, the team coordinates with qualified centres.
Questions we are asked
Common questions about AML treatment in older adults
Is there an upper age limit for AML treatment?
No fixed age limit exists. Treatment choices are based on fitness, other illnesses, the leukaemia type and what the person wants. Some people in their eighties have lower-intensity treatment. Some people in their sixties are too unwell for intensive treatment. Ask how your parent's health, not their age, shapes the advice.
Can an older person with AML have a transplant?
Occasionally. Some fit older adults are assessed for a reduced-intensity transplant at a qualified transplant centre. Most people over 70 are not suitable, because the risks are high. If this is a question for your family, ask the haematologist whether an assessment makes sense.
Will my father need to stay in hospital?
With intensive chemotherapy, usually for several weeks. With lower-intensity treatment, the first cycle is often started in hospital for safety, and later cycles are mostly day care. Admissions may still be needed for fever or infection. Ask what to expect for the plan chosen.
Can we change our mind after treatment starts?
Yes. Plans can be changed if treatment is too hard, is not working, or your parent's wishes change. Talk to the team rather than stopping medicines on your own, because a sudden stop can cause problems. The team can move to a gentler plan or to supportive care.
What if my mother has diabetes and heart problems?
These make intensive chemotherapy riskier and often point towards lower-intensity treatment. Her usual doctors may need to adjust her other medicines during treatment. Bring every prescription and recent report to the first appointment so the haematologist has the full picture.
How do we cope with frequent visits from a district?
Tell the team where you live at the first visit. Some blood tests may be done closer to home, and some families stay near the centre during the first cycle. Plan transport for emergencies too, because a fever cannot wait for the next bus.
Is supportive care the same as giving up?
No. Supportive care means treating symptoms, infections and low counts to keep your parent as comfortable and independent as possible. The team stays involved. For some people it is the choice that most closely matches what they want from the time ahead.
Is treatment for older adults covered by schemes?
Aarogyasri, PM-JAY, CGHS, ECHS, EHS and cashless insurance may cover parts of AML treatment, but rules differ between schemes and change over time. Check current entitlements before treatment starts. Call the helpline with the card details and we will help you check.
Your Haematologist
Meet CION's haematologist. One specialist for your blood report and your plan.
Dr. Basudev Pokhrel reviews blood counts, transfusion needs and blood disorders, and works with the CION tumour board on blood cancers.
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- Cancer Research UK — Treatment for acute myeloid leukaemia (AML)
- National Cancer Institute — Adult Acute Myeloid Leukemia Treatment (PDQ) - Patient Version
- American Cancer Society — Treating Acute Myeloid Leukemia (AML)
- Leukemia & Lymphoma Society — Acute Myeloid Leukemia
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Venetoclax and Azacitidine for Unfit AML PatientsThe most common lower-intensity optionAML Risk Groups and What They PredictHow genetic results shape the choiceAML Survival: What the Numbers Mean for YouWhat affects the outlook, without false numbersAML Treatment Cost in IndiaIndicative costs and scheme coverage
Talk to us
Facing this decision for a parent?
Tell us what has been found so far. CION's haematology team will review the reports and talk the options through with your family. One helpline serves every CION centre.